Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
about
Profile of palbociclib in the treatment of metastatic breast cancerEmerging therapies for breast cancerParthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells.Calycosin inhibits migration and invasion through modulation of transforming growth factor beta-mediated mesenchymal properties in U87 and U251 cellsCyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway.Progress with palbociclib in breast cancer: latest evidence and clinical considerations.Association between COX-2 -1195G>A polymorphism and gastrointestinal cancer risk: A meta-analysis.Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner.CDK4/6 inhibition is more active against the glioblastoma proneural subtype.GTSE1: a novel TEAD4-E2F1 target gene involved in cell protrusions formation in triple-negative breast cancer cell models.Metformin: A Bridge between Diabetes and Prostate Cancer.Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions.Epithelial-mesenchymal transition inducer Snail1 and invasive potential of intraductal breast cancer.The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia.Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells.Anesthetic drug propofol inhibits the expression of interleukin-6, interleukin-8 and cyclooxygenase-2, a potential mechanism for propofol in suppressing tumor development and metastasis.
P2860
Q26747737-F206D902-2483-4EA6-B9A9-AEEEEE091311Q33617949-DB281C52-2FF8-4142-9FAC-B67908F62D20Q33679117-B462DB17-BBF4-4C32-8042-8FEABC976A7CQ36624137-C453F9D1-5450-44D1-8AB9-7420361F89E3Q37513938-B73670E9-9D44-402E-A5E6-FFF4FD242CEBQ37632170-B0D8632F-A453-4E23-903D-F13FA2E1D05EQ37730897-E3E9E65C-2FA3-438B-9978-E308B9E76698Q38656581-2A6B014C-4D2F-4209-99F1-BF567B0CAE29Q41194460-208BB95E-6E22-4877-8146-A87B2508926DQ41548769-8466C459-F6D2-4B1A-9D1D-72D2A6B0BF48Q41991044-EB66EC88-F666-40BA-B2B8-6BF66907353DQ42700292-756D9085-84FD-4BE2-948D-FC953D65C06FQ47316489-D27C25E3-EA3B-4DE0-980B-1CDAE3F2A06FQ47821353-0BFBA11D-2D10-4A0D-BCCF-D2447ADF5513Q48169849-9A3B2F4B-495E-4702-B0A7-DF966D5B8F1BQ48231208-122AB2C1-89DE-437E-9D6E-E63632B04290Q55439493-66F5B572-6610-4E8A-965B-F90FD95B1412
P2860
Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Palbociclib inhibits epithelia ...... c-Jun/COX-2 signaling pathway.
@ast
Palbociclib inhibits epithelia ...... c-Jun/COX-2 signaling pathway.
@en
type
label
Palbociclib inhibits epithelia ...... c-Jun/COX-2 signaling pathway.
@ast
Palbociclib inhibits epithelia ...... c-Jun/COX-2 signaling pathway.
@en
prefLabel
Palbociclib inhibits epithelia ...... c-Jun/COX-2 signaling pathway.
@ast
Palbociclib inhibits epithelia ...... c-Jun/COX-2 signaling pathway.
@en
P2093
P2860
P356
P1433
P1476
Palbociclib inhibits epithelia ...... c-Jun/COX-2 signaling pathway
@en
P2093
Dingbo Shi
Jingshu Wang
Qiufan Zheng
Shusen Wang
Wuguo Deng
Xiangshen Xiao
P2860
P304
41794-41808
P356
10.18632/ONCOTARGET.5993
P407
P50
P577
2015-12-01T00:00:00Z